Efficacy of ACE inhibitor (captopril) on glomerular antioxidant enzyme activity and hypertension in diabetic hypertensive rats

Contributions to Nephrology

Volumn 134, Issue , 2001, Pages 74-78

  Shou, Ichiyu ^a   Fukui, Mitumine ^a   Tomino, Yasuhiko ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL; DIABETIC NEPHROPATHY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GLOMERULUS; HYPERTENSION; METABOLISM; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RAT; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIOXIDANTS; CAPTOPRIL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; HYPERTENSION; KIDNEY GLOMERULUS; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 0035538608     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060135     Document Type: Article

References (18)

1. Stratta P, Canvese C, Dogliani M, Mazzucco G, Vercellone A: The role of free radicals in the progression of renal disease. Kidney Int 1991;17(suppl):33-37.
2. Wang LN, Fukui M, Shou I, Yaguchi Y, Funabiki K, Horikoshi S, Tomino Y: Detection of antioxidant enzyme activities in renal tissues of early stage IgA nephropathy in ddy mice. J Clin Lab Anal 1996;10:394-398.
3. Morel DM, Chisolm GM: Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res 1989;30:1827-1834.
4. Cooper ME, Allen TJ, Macmillan PA, Clarke BE, O'Brien RC, Jerums G, Doyle AE: Effects of genetic hypertension on diabetic nephropathy in the rat: Functional and structural characteristics. J Hypertens 1988;6:1009-1016.
5. Cooper ME, Allen TJ, Macmillan PA, Clarke BE, O'Brien RC, Jerums G, Doyle AE: Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat. Diabetologia 1989;32:326-328.
6. Asayama K, Shiki Y, Ito H, Hasegawa O, Miyao A, Hayashibe H: Antioxidant enzymes in blood in uremic children and adolescents. Free Radic Biol Med 1990;9:105-109.
7. Yokoyama K, Sei C, Tomino Y, Koide H, Yamakura H, Ohmori D: Detection of serum SOD activity using ESR in patients with chronic glomerulonephritis and chronic renal failure; in Tomino Y, Ohwada S, Ito S (eds): Kidney and Free Radical in Kidney and Dialysis (in Japanese). Tokyo, Tokyo Igakusya, 1994, pp 205-207.
8. Omata M: Role of reactive oxygen species (ROS) in model immune complex nephritis (in Japanese). Jpn J Nephrol 1990;32:949-958.
9. Yoshioka T, Bills T, Moore-Jarrett T, Greene HL, Burr TM, Ichiawa I: Role of intrinsic antioxidant enzymes in renal oxidant injury. Kidney Int 1990;38:282-288.
10. Chora M, Beswick H, Clapperton M, Dargie HJ, Smith WE, McMurray J: Antioxidant effects of angiotensin converting enzyme (ACE) inhibitors: Free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydrylcontaining ACE inhibitors. J Cardiovasc Pharmacol 1992;19:330-340.
11. de Cavanagh EM, Inserra F, Ferder L, Romano L, Ercole L, Fraga CG: Superoxide disumutase and glutathione peroxidase activities are increased by enalapril and captopril in mouse liver. FEBS Lett 1995;361:22-24.
12. Kutyrina IM, Tareeva IE, Shestakova MV, Gerasimenko OI, Zverev KV, Rogov VA: The antiproteinuric action of angiotensin-coverting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy (in Russian). Ter Arkh 1994;66:19-22.
13. Liou HH, Huang TP, Campese VM. Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependant diabetes and with non-diabetic renal disease. Nephron 1995;69:41-48
14. Ravid M, Lang R, Rachmani R, Lishner M: Long-term renoprotective effect of angiotensinconverting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch Intern Med 1996;156:286-289.
15. Cattran DC, Greenwood C, Ritchie S: Long-term benefits of angiotensin-coverting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: A comparison to patients receiving treatment with other antihypertensive agents and to patients receiving to therapy. Am J Kidney Dis 1994;23:247-254.
16. Omata K, Kanazawa M, Sato T, Abe F, Saito T, Abe K: Therapeutic advantages of angiotensin coverting enzyme inhibitors in chronic renal disease. Kidney Int 1996;55(suppl):S57-S62.
17. Ito S, Abe K: Influence of anti-hypertensive drugs on glomerular hemodynamics. Nippon Jinzo Gakkai Shi 1996;38:115-118.
18. Tang Z, Shou I, Wang L, Fukui M, Tomino Y: Effects of antihypertensive drugs or glycemic control on antioxidant enzyme activities in spontaneously hypertensive rats with diabetes. Nephron 1997;76:323-330.